NHS England’s chief executive has told MPs he would support an independent review of the effectiveness of Palantir’s ...

The startling safety data from two new reviews on maternity services might be expected to trigger immediate measures for ...

The death of a man taking the unapproved next generation GLP-1 weight loss drug retatrutide made headlines in the national ...

Millions more Americans will now have access to GLP-1 drugs for weight loss under a new programme launched by the US ...

Variants of sexually transmitted Shigella are spreading more rapidly among sections of gay men in England than variants ...

A male basketball player in his 30s sustained a left knee injury during a game after a jump landing. He felt a sudden popping ...

Louise Newson, a high profile GP who runs a network of private menopause clinics, has been refused permission to seek ...

Ministers are being urged not to adopt a controversial BMA proposal that international medical graduates (IMGs) should have ...

Peter was born in 1925 and left school to join the Royal Navy in 1943, serving for three and a half years, initially on a ...

Ex-health secretary bids to become PM The former UK health secretary Andy Burnham confirmed his much anticipated bid to ...

Future work to improve maternity care must be trauma informed and listen to the needs of families, writes Jenny Ardley Our ...

Obesity drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) produce substantial weight loss for patients but do not ...